Mechanism of Compound Xinyi Nasal Drops in the Treatment of Allergic Rhinitis Through STAT3/IL‐17A/NF‐κB Signaling Pathway Based on Network Pharmacology and Experimental Verification
Biomedical Chromatography · 2026-08 · 40 (8)
DOI: 10.1002/bmc.70540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 06.07.2026. Verfasst von Congwen Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Grade Three-level Laboratory of TCM Preparation, State Administration of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui Univers…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Drugs, Chinese Herbal, Signal Transduction, Rhinitis, Allergic. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Kunshan Traditional Chinese Medicine science and technology development fund project, Anhui Province Traditional Chinese Medicine Inheritance and Innovation Research Project, Key Project of Natural Science Foundation of Anhui Province Higher Education Institution.
Abstract (Originalsprache)
Compound Xinyi nasal drops (CXND) is a traditional Chinese medicine nasal drop developed from an empirical clinical prescription for the treatment of allergic rhinitis and has been used for more than 20 years, with precise therapeutic efficacy. However, the mechanism of action of CXND in treating allergic rhinitis remains unclear. Investigating the impact of CXND on allergic rhinitis and further defining its potential active ingredients and mechanism of action were the objectives of this study. The effective components of CXND were determined by ultra‐performance liquid chromatography, and the core genes and important pathways of CXND in the treatment of AR were analyzed by network pharmacology. Then, molecular docking verified component‐target binding activity. The guinea pig model was induced by OVA to study the effects of CXND on the STAT3/IL‐17A/NF‐κB signaling pathway and related inflammatory factors. The fingerprint spectrum of CXND was established, and seven effective components were identified. It was found that the seven components might exert their therapeutic effects on allergic rhinitis through the STAT3/IL‐17A/NF‐κB signaling pathway. In vivo experiments have found that CXND can effectively reduce the levels of IL‐6, IL‐17A, and TNF‐α while inhibiting the expression levels of STAT3, IL‐17A, NF‐κB p65 mRNA, and their phosphorylated proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grade Three-level Laboratory of TCM Preparation, State Administration of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
- Kunshan Hospital of Chinese Medicine, Kunshan, China.
- College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
- College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China.
ORCID-Profile: Congwen Gu, Yanquan Han
Förderung
- Kunshan Traditional Chinese Medicine science and technology development fund project
- Anhui Province Traditional Chinese Medicine Inheritance and Innovation Research Project
- Key Project of Natural Science Foundation of Anhui Province Higher Education Institution
- New era education quality project of Anhui Provincial Department of Education
- Zhejiang Provincial University Key Characteristic Discipline (Chinese Materia Medica)
Zitieren
APA
Gu, C., Tan, J., Gen, S., Cao, G., Hong, Y., & Han, Y. (2026). Mechanism of Compound Xinyi Nasal Drops in the Treatment of Allergic Rhinitis Through STAT3/IL‐17A/NF‐κB Signaling Pathway Based on Network Pharmacology and Experimental Verification. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70540
Vancouver
Gu C, Tan J, Gen S, Cao G, Hong Y, Han Y. Mechanism of Compound Xinyi Nasal Drops in the Treatment of Allergic Rhinitis Through STAT3/IL‐17A/NF‐κB Signaling Pathway Based on Network Pharmacology and Experimental Verification. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70540
BibTeX
@article{Gu2026,
author = {Gu, Congwen and Tan, Jiaxin and Gen, Shuang and Cao, Gang and Hong, Yan and Han, Yanquan},
title = {Mechanism of Compound Xinyi Nasal Drops in the Treatment of Allergic Rhinitis Through STAT3/IL‐17A/NF‐κB Signaling Pathway Based on Network Pharmacology and Experimental Verification},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {8},
doi = {10.1002/bmc.70540}
}
EUVIMED